Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Razani, B.
	Articles by Lisanti, M. P.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Razani, B.
	Articles by Lisanti, M. P.


Social Bookmarking

	What's this?

Achille, A., Biasi, M. O., Zamboni, G., Bogina, G., Magalini, A. R., Pederzoli, P., Perucho, M. and Scarpa, A (1996). Chromosome 7q allelic losses in pancreatic carcinoma. Cancer Res 56, 3808-3813.[Abstract/Free Full Text]

Anderson, R. G. W (1998). The caveolae membrane system. Annu. Rev. Biochem 67, 199-225.[Medline]

Bieche, I., Champeme, M. H., Matifas, F., Hacene, K., Callahan, R. and Lidereau, R (1992). Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer. Lancet 339, 139-143.[Medline]

Carman, C. V., Lisanti, M. P. and Benovic, J. L (1999). Regulation of G protein-coupled receptor kinases (GRKs) by caveolin. J. Biol. Chem 274, 8858-8864.[Abstract/Free Full Text]

Champeme, M. H., Bieche, I., Beuzelin, M. and Lidereau, R (1995). Loss of heterozygosity on 7q31 occurs early during breast tumorigenesis. Genes Chromosomes Cancer 12, 304-306.[Medline]

Couet, J., Li., S., Okamoto, T., Ikezu, T. and Lisanti, M. P (1997). Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J. Biol. Chem 272, 6525-6533.[Abstract/Free Full Text]

Couet, J., Sargiacomo, M. and Lisanti, M. P (1997). Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem 272, 30429-30438.[Abstract/Free Full Text]

Engelman, J. A., Wycoff, C. C., Yasuhara, S., Song, K. S., Okamoto, T. and Lisanti, M. P (1997). Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J. Biol. Chem 272, 16374-16381.[Abstract/Free Full Text]

Engelman, J. A., Lee, R. J., Karnezis, A., Bearss, D. J., Webster, M., Siegel, P., Muller, W. J., Windle, J. J., Pestell, R. G. and Lisanti, M. P (1998). Reciprocal regulation of Neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer. J. Biol. Chem 273, 20448-20455.[Abstract/Free Full Text]

Engelman, J. A., Zhang, X. L., Galbiati, F. and Lisanti, M. P (1998). Chromosomal localization, genomic organization and developmental expression of the murine caveolin gene family (Cav-1,-2 and-3). Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/ 7q31). FEBS Lett 429, 330-336.[Medline]

Engelman, J. A., Zhang, X. L., Galbiati, F., Volonte, D., Sotgia, F., Pestell,R. G., Minetti, C., Scherer, P. E., Okamoto, T. and Lisanti, M. P (1998). Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer's disease and muscular dystrophy. Am. J. Hum. Genet 63, 1578-1587.[Medline]

Engelman, J. A., Zhang, X. L. and Lisanti, M. P (1999). Sequence and detailed organization of the human caveolin-1 and-2 genes located near the D7S522 locus (7q31. 1). Methylation of a CpG island in the 5' promoter region of the caveolin-1 gene in human breast cancer cell lines. FEBS Lett 448, 221-230.[Medline]

Fra, A. M., Masserini, M., Palestini, P., Sonnino, S. and Simons, K (1995). A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface. FEBS Lett 375, 11-14.[Medline]

Galbiati, F., Volonte, D., Engelman, J. A., Watanabe, G., Burk, R., Pestell, R. and Lisanti, M. P (1998). Targeted down-regulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 17, 6633-6648.[Medline]

Galbiati, F., Volonte, V., Minetti, C., Chu, J. B. and Lisanti, M. P (1999). Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the Golgi complex. J. Biol. Chem 274, 25632-25641.[Abstract/Free Full Text]

Huang, H., Qian, C., Jenkins, R. B. and Smith, D. I (1998). Fish mapping of YAC clones at human chromosomal band 7q31. 2: identification of YACS spanning FRA7G within the common region of LOH in breast and prostate cancer. Genes Chromosomes Cancer 21, 152-159.[Medline]

Iwanishi, M., Haruta, T., Takata, Y., Ishibashi, O., Sasaoka, T., Egawa, K., Imamura, T., Naitou, K., Itazu, T. and Kobayashi, M (1993). A mutation (Trp1193-Leu1193) in the tyrosine kinase domain of the insulin receptor associated with type A syndrome of insulin resistance. Diabetologia 36, 414-422.[Medline]

Jenkins, R., Takahashi, S., DeLacey, K., Bergstralh, E. and Lieber, M (1998). Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q and 18q in stage T3N0M0 prostate cancer. Genes Chromosomes Cancer 21, 131-143.[Medline]

Jenkins, R. B., Qian, J., Lee, H. K., Huang, H., Hirasawa, K., Bostwick, D. G., Proffitt, J., Wilber, K., Lieber, M. M., Liu, W. and Smith, D. I (1998). A molecular cytogenetic analysis of 7q31 in prostate cancer. Cancer Res 58, 759-766.[Abstract/Free Full Text]

Kerr, J., Leary, J. A., Hurst, T., Shih, Y. C., Antalis, T. M., Friedlander, M., Crawford, E., Khoo, S. K., Ward, B. and Chenevix-Trench, G (1996). Allelic loss on chromosome 7q in ovarian adenocarcinomas: two critical regions and a rearrangement of the PLANH1 locus. Oncogene 13, 1815-1818.[Medline]

Koike, M., Takeuchi, S., Yokota, J., Park, S., Hatta, Y., Miller, C. W., Tsuruoka, N. and Koeffler, H. P (1997). Frequent loss of heterozygosity in the region of the D7S523 locus in advanced ovarian cancer. Genes Chromosomes Cancer 19, 1-5.[Medline]

Koleske, A. J., Baltimore, D. and Lisanti, M. P (1995). Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Nat. Acad. Sci. USA 92, 1381-1385.[Abstract/Free Full Text]

Laxman, R., Currie, J. L., Kurman, R. J., Dudzinski, M. and Griffin, C. A (1993). Cytogenetic profile of uterine sarcomas. Cancer 71, 1283-1288.[Medline]

Lee, S. W., Reimer, C. L., Oh, P., Campbel, l. D. B. and Schnitzer, J. E (1998). Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 16, 1391-1397.[Medline]

Li, S., Okamoto, T., Chun, M., Sargiacomo, M., Casanova, J. E., Hansen, S. H., Nishimoto, I. and Lisanti, M. P (1995). Evidence for a regulated interaction of hetero-trimeric G proteins with caveolin. J. Biol. Chem 270, 15693-15701.[Abstract/Free Full Text]

Li, S., Couet, J. and Lisanti, M. P (1996). Src tyrosine kinases, G alpha subunits and H-Ras share a common membrane-anchored scaffolding protein, Caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J. Biol. Chem 271, 29182-29190.[Abstract/Free Full Text]

Li, S., Song, K. S., Koh, S. S., Kikuchi, A. and Lisanti, M. P (1996). Baculovirus-based expression of mammalian caveolin in Sf21 insect cells:A model system for the biochemical and morphological study of caveolar biogenesis. J. Biol. Chem 271, 28647-28654.[Abstract/Free Full Text]

Li, S., Song, K. S and Lisanti, M. P (1996). Expression and characterization of recombinant caveolin: Purification by poly-histidine tagging and cholesterol-dependent incorporation into defined lipid membranes. J. Biol. Chem 271, 568-573.[Abstract/Free Full Text]

Lin, J. C., Scherer, S. W., Tougas, L., Traverso, G., Tsui, L. C., Andrulis, I. L., Jothy, S. and Park, M (1996). Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET. Oncogene 13, 2001-2008.[Medline]

Matsuura, K., Shiga, K., Yokoyama, J., Saijo, S., Miyagi, T. and Takasaka, T (1998). Loss of heterozygosity of chromosome 9p21 and 7q31 is correlated with high incidence of recurrent tumor in head and neck squamous cell carcinoma. Anticancer Res 18, 453-458.[Medline]

McNally, E. M., de S\207 Moreira, E., Duggan, D. J., B\232nnemann, C. G., Lisanti, M. P., Lidov, H. G. W., Vainzof, M., Passos-Bueno, M. R., Hoffman, E. P., Zatz, M. and Kunkel, L. M (1998). Caveolin-3 in muscular dystrophy. Human Mol. Gen 7, 871-877.[Abstract/Free Full Text]

Minetti, C., Sotgia, F., Bruno, C., Scartezzini, P., Broda, P., Bado, M., Masetti, E., Mazzocco, P., Egeo, A., Donati, M. A., Volonte', D., Galbiati, F., Cordone, G., Bricarelli, F. D., Lisanti, M. P. and Zara, F (1998). Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nature Genet 18, 365-368.[Medline]

Moller, D. E., Yokota, A., Ginsberg-Fellner, F. and Flier, J. S (1990). Functional properties of a naturally occurring Trp1200-Ser1200 mutation of the insulin receptor. Mol. Endocrinol 4, 1183-1191.[Abstract/Free Full Text]

Monier, S., Parton, R. G., Vogel, F., Behlke, J., Henske, A. and Kurzchalia, T (1995). VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro. Mol. Biol. Cell 6, 911-927.[Abstract]

Monier, S., Dietzen, D. J., Hastings, W. R., Lublin, D. M. and Kurzchalia, T. V (1996). Oligomerization of VIP21-caveolin in vitro is stabilized by long chain fatty acylation or cholesterol. FEBS Lett 388, 143-149.[Medline]

Murata, M., Peranen, J., Schreiner, R., Weiland, F., Kurzchalia, T. and Simons, K (1995). VIP21/caveolin is a cholesterol-binding protein. Proc. Nat. Acad. Sci. USA 92, 10339-10343.[Abstract/Free Full Text]

Nystrom, F. H., Chen, H., Cong, L.-N., Li, Y. and Quon, M. J (1999). Caveolin-1 interacts with the insulin receptor and can differentially modulate insulin signaling in transfected Cos-7 cells and rat adipose cells. Mol. Endocrinol 12, 2013-2024.

Oakahashi, S., Shan, A. L., Ritland, S. R., Delacey, K. A., Bostwick, D. G., Lieber, M. M., Thibodeau, S. N. and Jenkins, R. B (1995). Frequent loss of heterozygosity at 7q31. 1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Res 55, 4114-4119.[Abstract/Free Full Text]

Palade, G. E. and Bruns, R. R (1968). Structural modification of plasmalemma vesicles. J. Cell Biol 37, 633-649.

Parton, R. G (1996). Caveolae and caveolins. Curr. Opin. Cell Biol 8, 542-548.[Medline]

Parton, R. G., Way, M., Zorzi, N. and Stang, E (1997). Caveolin-3 associates with developing T-tubules during muscle differentiation. J. Cell Biol 136, 137-154.[Abstract/Free Full Text]

Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y., Glenney, J. R. and Anderson, R. G. W (1992). Caveolin, a protein component of caveolae membrane coats. Cell 68, 673-682.[Medline]

Sargiacomo, M., Sudol, M., Tang, Z.-L. and Lisanti, M. P (1993). Signal transducing molecules and GPI-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J. Cell Biol 122, 789-807.[Abstract/Free Full Text]

Sargiacomo, M., Scherer, P. E., Tang, Z.-L., Kubler, E., Song, K. S.,Sanders, M. C. and Lisanti, M. P (1995). Oligomeric structure of caveolin: Implications for caveolae membrane organization. Proc. Nat. Acad. Sci. USA 92, 9407-9411.[Abstract/Free Full Text]

Scherer, P. E., Okamoto, T., Chun, M., Nishimoto, I., Lodish, H. F. andLisanti, M. P (1996). Identification, sequence and expression of caveolin-2 defines a caveolin gene family. Proc. Nat. Acad. Sci. USA 93, 131-135.[Abstract/Free Full Text]

Scherer, P. E., Lewis, R. Y., Volonte, D., Engelman, J. A., Galbiati, F., Couet, J., Kohtz, D. S., van Donselaar, E., Peters, P. and Lisanti, M. P (1997). Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J. Biol. Chem 272, 29337-29346.[Abstract/Free Full Text]

Shridhar, V., Sun, Q. C., Miller, O. J., Kalemkerian, G. P., Petros, J. and Smith, D. I (1997). Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas. Oncogene 15, 2727-2733.[Medline]

Simionescu, N (1983). Cellular aspects of transcapillary exchange. Physiol. Rev 63, 1536-1560.[Free Full Text]

Song, K. S., Li, S., Okamoto, T., Quilliam, L., Sargiacomo, M. and Lisanti, M. P (1996). Copurification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent free purification of caveolae membranes. J. Biol. Chem 271, 9690-9697.[Abstract/Free Full Text]

Song, K. S., Scherer, P. E., Tang, Z.-L., Okamoto, T., Li, S., Chafel, M., Chu, C., Kohtz, D. S. and Lisanti, M. P (1996). Expression of caveolin-3 in skeletal, cardiac and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J. Biol. Chem 271, 15160-15165.[Abstract/Free Full Text]

Sotgia, F., Minetti, C. and Lisanti, M. P (1999). Localization of the human caveolin-3 gene to the D3S18/D3S4163/ D3S4539 locus (3p25), in close proximity to the human oxytocin receptor gene. Identification of the caveolin-3 gene as a candidate for deletion in 3p-syndrome. FEBS Lett 452, 177-180.[Medline]

Tang, Z.-L., Scherer, P. E., Okamoto, T., Song, K., Chu, C., Kohtz, D. S., Nishimoto, I., Lodish, H. F. and Lisanti, M. P (1996). Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J. Biol. Chem 271, 2255-2261.[Abstract/Free Full Text]

Tang, Z., Okamoto, T., Boontrakulpoontawee, P., Katada, T., Otsuka, A. J. and Lisanti, M. P (1997). Identification, sequenceand expression of an invertebrate caveolin gene family from the nematode Caenorhabditis elegans : implications for the molecular evolution of mammalian caveolin genes. J. Biol. Chem 272, 2437-2445.[Abstract/Free Full Text]

Wang, X. L., Uzawa, K., Miyakawa, A., Shiiba, M., Watanabe, T., Sato, T., Miya, T., Yokoe, H. and Tanzawa, H (1998). Localization of a tumour-suppressor gene associated with human oral cancer on 7q31. 1. Int. J. Cancer 75, 671-674.[Medline]

Xiu, Z. F (1993). A preliminary cytogenetic study of uterine leiomyoma. Chung Hua Fu Chan Ko Tsa Chih 28, 91-93.

Yamamoto, M., Toya, Y., Schwencke, C., Lisanti, M. P., Myers, M. and Ishikawa, Y (1998). Caveolin is an activator of insulin receptor signaling. J. Biol. Chem 273, 26962-26968.[Abstract/Free Full Text]

Zenklusen, J. C., Bieche, I., Lidereau, R. and Conti, C. J (1994). (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc. Nat. Acad. Sci. USA 91, 12155-12158.[Abstract/Free Full Text]

Zenklusen, J. C., Thompson, J. C., Troncoso, P., Kagan, J. and Conti, C. J (1994). Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31. 1. Cancer Res 54, 6370-6373.[Abstract/Free Full Text]

Zenklusen, J. C., Thompson, J. C., Klein-Szanto, A. J. and Conti, C. J (1995). Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31. 1: evidence for a broad range tumor suppressor gene. Cancer Res 55, 1347-1350.[Abstract/Free Full Text]

Zenklusen, J. C., Weitzel, J. N., Ball, H. G. and Conti, C. J (1995). Allelic loss at 7q31. 1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene. Oncogene 11, 359-363.[Medline]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

Technorati

Twitter What's this?

This article has been cited by other articles:

D. J. Hernandez-Deviez, M. T. Howes, S. H. Laval, K. Bushby, J. F. Hancock, and R. G. Parton
Caveolin Regulates Endocytosis of the Muscle Repair Protein, Dysferlin
J. Biol. Chem., March 7, 2008; 283(10): 6476 - 6488.
[Abstract] [Full Text] [PDF]

K. Padhan, C. Tanwar, A. Hussain, P. Y. Hui, M. Y. Lee, C. Y. Cheung, J. S. M. Peiris, and S. Jameel
Severe acute respiratory syndrome coronavirus Orf3a protein interacts with caveolin
J. Gen. Virol., November 1, 2007; 88(11): 3067 - 3077.
[Abstract] [Full Text] [PDF]

Z. Xiao, F. Schmitz, V. E. Pricolo, P. Biancani, and J. Behar
Role of caveolae in the pathogenesis of cholesterol-induced gallbladder muscle hypomotility
Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1641 - G1649.
[Abstract] [Full Text] [PDF]

K. Savage, M. B.K. Lambros, D. Robertson, R. L. Jones, C. Jones, A. Mackay, M. James, J. L. Hornick, E. M. Pereira, F. Milanezi, et al.
Caveolin 1 Is Overexpressed and Amplified in a Subset of Basal-like and Metaplastic Breast Carcinomas: A Morphologic, Ultrastructural, Immunohistochemical, and In situ Hybridization Analysis
Clin. Cancer Res., January 1, 2007; 13(1): 90 - 101.
[Abstract] [Full Text] [PDF]

C. A. Shaw, N. Larochelle, R. W.R. Dudley, H. Lochmuller, G. Danialou, B. J. Petrof, G. Karpati, P. C. Holland, and J. Nalbantoglu
Simultaneous Dystrophin and Dysferlin Deficiencies Associated with High-Level Expression of the Coxsackie and Adenovirus Receptor in Transgenic Mice
Am. J. Pathol., December 1, 2006; 169(6): 2148 - 2160.
[Abstract] [Full Text] [PDF]

C. Schwencke, R. C. Braun-Dullaeus, C. Wunderlich, and R. H. Strasser
Caveolae and caveolin in transmembrane signaling: Implications for human disease
Cardiovasc Res, April 1, 2006; 70(1): 42 - 49.
[Abstract] [Full Text] [PDF]

D. J. Hernandez-Deviez, S. Martin, S. H. Laval, H. P. Lo, S. T. Cooper, K. N. North, K. Bushby, and R. G. Parton
Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3
Hum. Mol. Genet., January 1, 2006; 15(1): 129 - 142.
[Abstract] [Full Text] [PDF]

D. Mehta and A. B. Malik
Signaling Mechanisms Regulating Endothelial Permeability
Physiol Rev, January 1, 2006; 86(1): 279 - 367.
[Abstract] [Full Text] [PDF]

C. Schwencke, A. Schmeisser, C. Walter, R. Wachter, S. Pannach, B. Weck, R. C. Braun-Dullaeus, M. Kasper, and R. H. Strasser
Decreased caveolin-1 in atheroma: Loss of antiproliferative control of vascular smooth muscle cells in atherosclerosis
Cardiovasc Res, October 1, 2005; 68(1): 128 - 135.
[Abstract] [Full Text] [PDF]

E. Gonzalez, A. Nagiel, A. J. Lin, D. E. Golan, and T. Michel
Small Interfering RNA-mediated Down-regulation of Caveolin-1 Differentially Modulates Signaling Pathways in Endothelial Cells
J. Biol. Chem., September 24, 2004; 279(39): 40659 - 40669.
[Abstract] [Full Text] [PDF]

J.-F. Jasmin, I. Mercier, R. Hnasko, M. W.-C Cheung, H. B Tanowitz, J. Dupuis, and M. P Lisanti
Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression
Cardiovasc Res, September 1, 2004; 63(4): 747 - 755.
[Abstract] [Full Text] [PDF]

H. Zhang, P. H. Links, J. K. Ngsee, K. Tran, Z. Cui, K. W. S. Ko, and Z. Yao
Localization of Low Density Lipoprotein Receptor-related Protein 1 to Caveolae in 3T3-L1 Adipocytes in Response to Insulin Treatment
J. Biol. Chem., January 16, 2004; 279(3): 2221 - 2230.
[Abstract] [Full Text] [PDF]

Y. Ohsawa, H. Toko, M. Katsura, K. Morimoto, H. Yamada, Y. Ichikawa, T. Murakami, S. Ohkuma, I. Komuro, and Y. Sunada
Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity
Hum. Mol. Genet., January 15, 2004; 13(2): 151 - 157.
[Abstract] [Full Text] [PDF]

G. M. Smythe, J. C. Eby, M.-H. Disatnik, and T. A. Rando
A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes
J. Cell Sci., December 1, 2003; 116(23): 4739 - 4749.
[Abstract] [Full Text] [PDF]

S.-c. W. Brazer, B. B. Singh, X. Liu, W. Swaim, and I. S. Ambudkar
Caveolin-1 Contributes to Assembly of Store-operated Ca2+ Influx Channels by Regulating Plasma Membrane Localization of TRPC1
J. Biol. Chem., July 11, 2003; 278(29): 27208 - 27215.
[Abstract] [Full Text] [PDF]

D. S. Park, H. Lee, P. G. Frank, B. Razani, A. V. Nguyen, A. F. Parlow, R. G. Russell, J. Hulit, R. G. Pestell, and M. P. Lisanti
Caveolin-1-deficient Mice Show Accelerated Mammary Gland Development During Pregnancy, Premature Lactation, and Hyperactivation of the Jak-2/STAT5a Signaling Cascade
Mol. Biol. Cell, October 1, 2002; 13(10): 3416 - 3430.
[Abstract] [Full Text] [PDF]

B. Razani, S. E. Woodman, and M. P. Lisanti
Caveolae: From Cell Biology to Animal Physiology
Pharmacol. Rev., September 1, 2002; 54(3): 431 - 467.
[Abstract] [Full Text] [PDF]

A. J. Carozzi, S. Roy, I. C. Morrow, A. Pol, B. Wyse, J. Clyde-Smith, I. A. Prior, S. J. Nixon, J. F. Hancock, and R. G. Parton
Inhibition of Lipid Raft-dependent Signaling by a Dystrophy-associated Mutant of Caveolin-3
J. Biol. Chem., May 10, 2002; 277(20): 17944 - 17949.
[Abstract] [Full Text] [PDF]

M. A. Alonso and J. Millan
The role of lipid rafts in signalling and membrane trafficking in T lymphocytes
J. Cell Sci., March 13, 2002; 114(22): 3957 - 3965.
[Abstract] [Full Text] [PDF]

L. Vargas, B. F. Nore, A. Berglof, J. E. Heinonen, P. T. Mattsson, C. I. E. Smith, and A. J. Mohamed
Functional Interaction of Caveolin-1 with Bruton's Tyrosine Kinase and Bmx
J. Biol. Chem., March 8, 2002; 277(11): 9351 - 9357.
[Abstract] [Full Text] [PDF]

P. D. Cote, H. Moukhles, and S. Carbonetto
Dystroglycan Is Not Required for Localization of Dystrophin, Syntrophin, and Neuronal Nitric-oxide Synthase at the Sarcolemma but Regulates Integrin alpha 7B Expression and Caveolin-3 Distribution
J. Biol. Chem., February 8, 2002; 277(7): 4672 - 4679.
[Abstract] [Full Text] [PDF]

C. Minetti, M. Bado, P. Broda, F. Sotgia, C. Bruno, F. Galbiati, D. Volonte, G. Lucania, A. Pavan, E. Bonilla, et al.
Impairment of Caveolae Formation and T-System Disorganization in Human Muscular Dystrophy with Caveolin-3 Deficiency
Am. J. Pathol., January 1, 2002; 160(1): 265 - 270.
[Abstract] [Full Text] [PDF]

P. Thomsen, K. Roepstorff, M. Stahlhut, and B. van Deurs
Caveolae Are Highly Immobile Plasma Membrane Microdomains, Which Are not Involved in Constitutive Endocytic Trafficking
Mol. Biol. Cell, January 1, 2002; 13(1): 238 - 250.
[Abstract] [Full Text] [PDF]

B. Razani and M. P. Lisanti
Two distinct caveolin-1 domains mediate the functional interaction of caveolin-1 with protein kinase A
Am J Physiol Cell Physiol, October 1, 2001; 281(4): C1241 - C1250.
[Abstract] [Full Text] [PDF]

F. Galbiati, D. Volonte', J. Liu, F. Capozza, P. G. Frank, L. Zhu, R. G. Pestell, and M. P. Lisanti
Caveolin-1 Expression Negatively Regulates Cell Cycle Progression by Inducing G0/G1 Arrest via a p53/p21WAF1/Cip1-dependent Mechanism
Mol. Biol. Cell, August 1, 2001; 12(8): 2229 - 2244.
[Abstract] [Full Text] [PDF]

K. Hayashi, S. Matsuda, K. Machida, T. Yamamoto, Y. Fukuda, Y. Nimura, T. Hayakawa, and M. Hamaguchi
Invasion Activating Caveolin-1 Mutation in Human Scirrhous Breast Cancers
Cancer Res., March 1, 2001; 61(6): 2361 - 2364.
[Abstract] [Full Text]

R. Herrmann, V. Straub, M. Blank, C. Kutzick, N. Franke, E. N. Jacob, H.-G. Lenard, S. Kroger, and T. Voit
Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy
Hum. Mol. Genet., September 1, 2000; 9(15): 2335 - 2340.
[Abstract] [Full Text] [PDF]

F. Galbiati, D. Volonte', A. M. C. Brown, D. E. Weinstein, A. Ben-Ze'ev, R. G. Pestell, and M. P. Lisanti
Caveolin-1 Expression Inhibits Wnt/beta -Catenin/Lef-1 Signaling by Recruiting beta -Catenin to Caveolae Membrane Domains
J. Biol. Chem., July 21, 2000; 275(30): 23368 - 23377.
[Abstract] [Full Text] [PDF]

A. Schlegel and M. P. Lisanti
A Molecular Dissection of Caveolin-1 Membrane Attachment and Oligomerization. TWO SEPARATE REGIONS OF THE CAVEOLIN-1 C-TERMINAL DOMAIN MEDIATE MEMBRANE BINDING AND OLIGOMER/OLIGOMER INTERACTIONS IN VIVO
J. Biol. Chem., July 7, 2000; 275(28): 21605 - 21617.
[Abstract] [Full Text] [PDF]

F. Sotgia, J. K. Lee, K. Das, M. Bedford, T. C. Petrucci, P. Macioce, M. Sargiacomo, F. D. Bricarelli, C. Minetti, M. Sudol, et al.
Caveolin-3 Directly Interacts with the C-terminal Tail of beta -Dystroglycan. IDENTIFICATION OF A CENTRAL WW-LIKE DOMAIN WITHIN CAVEOLIN FAMILY MEMBERS
J. Biol. Chem., November 22, 2000; 275(48): 38048 - 38058.
[Abstract] [Full Text] [PDF]

F. Galbiati, D. Volonte, C. Minetti, D. B. Bregman, and M. P. Lisanti
Limb-girdle Muscular Dystrophy (LGMD-1C) Mutants of Caveolin-3 Undergo Ubiquitination and Proteasomal Degradation. TREATMENT WITH PROTEASOMAL INHIBITORS BLOCKS THE DOMINANT NEGATIVE EFFECT OF LGMD-1C MUTANTS AND RESCUES WILD-TYPE CAVEOLIN-3
J. Biol. Chem., November 22, 2000; 275(48): 37702 - 37711.
[Abstract] [Full Text] [PDF]

B. Razani, X. L. Zhang, M. Bitzer, G. von Gersdorff, E. P. Bottinger, and M. P. Lisanti
Caveolin-1 Regulates Transforming Growth Factor (TGF)-beta /SMAD Signaling through an Interaction with the TGF-beta Type I Receptor
J. Biol. Chem., February 23, 2001; 276(9): 6727 - 6738.
[Abstract] [Full Text] [PDF]

B. Razani, J. A. Engelman, X. B. Wang, W. Schubert, X. L. Zhang, C. B. Marks, F. Macaluso, R. G. Russell, M. Li, R. G. Pestell, et al.
Caveolin-1 Null Mice Are Viable but Show Evidence of Hyperproliferative and Vascular Abnormalities
J. Biol. Chem., October 5, 2001; 276(41): 38121 - 38138.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Razani, B.

Articles by Lisanti, M. P.

Search for Related Content

PubMed

PubMed Citation

Articles by Razani, B.

Articles by Lisanti, M. P.

Social Bookmarking

What's this?

				K. Padhan, C. Tanwar, A. Hussain, P. Y. Hui, M. Y. Lee, C. Y. Cheung, J. S. M. Peiris, and S. Jameel Severe acute respiratory syndrome coronavirus Orf3a protein interacts with caveolin J. Gen. Virol., November 1, 2007; 88(11): 3067 - 3077. [Abstract] [Full Text] [PDF]

				Z. Xiao, F. Schmitz, V. E. Pricolo, P. Biancani, and J. Behar Role of caveolae in the pathogenesis of cholesterol-induced gallbladder muscle hypomotility Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1641 - G1649. [Abstract] [Full Text] [PDF]

				K. Savage, M. B.K. Lambros, D. Robertson, R. L. Jones, C. Jones, A. Mackay, M. James, J. L. Hornick, E. M. Pereira, F. Milanezi, et al. Caveolin 1 Is Overexpressed and Amplified in a Subset of Basal-like and Metaplastic Breast Carcinomas: A Morphologic, Ultrastructural, Immunohistochemical, and In situ Hybridization Analysis Clin. Cancer Res., January 1, 2007; 13(1): 90 - 101. [Abstract] [Full Text] [PDF]

				C. A. Shaw, N. Larochelle, R. W.R. Dudley, H. Lochmuller, G. Danialou, B. J. Petrof, G. Karpati, P. C. Holland, and J. Nalbantoglu Simultaneous Dystrophin and Dysferlin Deficiencies Associated with High-Level Expression of the Coxsackie and Adenovirus Receptor in Transgenic Mice Am. J. Pathol., December 1, 2006; 169(6): 2148 - 2160. [Abstract] [Full Text] [PDF]

				C. Schwencke, R. C. Braun-Dullaeus, C. Wunderlich, and R. H. Strasser Caveolae and caveolin in transmembrane signaling: Implications for human disease Cardiovasc Res, April 1, 2006; 70(1): 42 - 49. [Abstract] [Full Text] [PDF]

				D. J. Hernandez-Deviez, S. Martin, S. H. Laval, H. P. Lo, S. T. Cooper, K. N. North, K. Bushby, and R. G. Parton Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3 Hum. Mol. Genet., January 1, 2006; 15(1): 129 - 142. [Abstract] [Full Text] [PDF]

				D. Mehta and A. B. Malik Signaling Mechanisms Regulating Endothelial Permeability Physiol Rev, January 1, 2006; 86(1): 279 - 367. [Abstract] [Full Text] [PDF]

				C. Schwencke, A. Schmeisser, C. Walter, R. Wachter, S. Pannach, B. Weck, R. C. Braun-Dullaeus, M. Kasper, and R. H. Strasser Decreased caveolin-1 in atheroma: Loss of antiproliferative control of vascular smooth muscle cells in atherosclerosis Cardiovasc Res, October 1, 2005; 68(1): 128 - 135. [Abstract] [Full Text] [PDF]

				E. Gonzalez, A. Nagiel, A. J. Lin, D. E. Golan, and T. Michel Small Interfering RNA-mediated Down-regulation of Caveolin-1 Differentially Modulates Signaling Pathways in Endothelial Cells J. Biol. Chem., September 24, 2004; 279(39): 40659 - 40669. [Abstract] [Full Text] [PDF]

				J.-F. Jasmin, I. Mercier, R. Hnasko, M. W.-C Cheung, H. B Tanowitz, J. Dupuis, and M. P Lisanti Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression Cardiovasc Res, September 1, 2004; 63(4): 747 - 755. [Abstract] [Full Text] [PDF]

				H. Zhang, P. H. Links, J. K. Ngsee, K. Tran, Z. Cui, K. W. S. Ko, and Z. Yao Localization of Low Density Lipoprotein Receptor-related Protein 1 to Caveolae in 3T3-L1 Adipocytes in Response to Insulin Treatment J. Biol. Chem., January 16, 2004; 279(3): 2221 - 2230. [Abstract] [Full Text] [PDF]

				Y. Ohsawa, H. Toko, M. Katsura, K. Morimoto, H. Yamada, Y. Ichikawa, T. Murakami, S. Ohkuma, I. Komuro, and Y. Sunada Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity Hum. Mol. Genet., January 15, 2004; 13(2): 151 - 157. [Abstract] [Full Text] [PDF]

				G. M. Smythe, J. C. Eby, M.-H. Disatnik, and T. A. Rando A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes J. Cell Sci., December 1, 2003; 116(23): 4739 - 4749. [Abstract] [Full Text] [PDF]

				S.-c. W. Brazer, B. B. Singh, X. Liu, W. Swaim, and I. S. Ambudkar Caveolin-1 Contributes to Assembly of Store-operated Ca2+ Influx Channels by Regulating Plasma Membrane Localization of TRPC1 J. Biol. Chem., July 11, 2003; 278(29): 27208 - 27215. [Abstract] [Full Text] [PDF]

				D. S. Park, H. Lee, P. G. Frank, B. Razani, A. V. Nguyen, A. F. Parlow, R. G. Russell, J. Hulit, R. G. Pestell, and M. P. Lisanti Caveolin-1-deficient Mice Show Accelerated Mammary Gland Development During Pregnancy, Premature Lactation, and Hyperactivation of the Jak-2/STAT5a Signaling Cascade Mol. Biol. Cell, October 1, 2002; 13(10): 3416 - 3430. [Abstract] [Full Text] [PDF]

				B. Razani, S. E. Woodman, and M. P. Lisanti Caveolae: From Cell Biology to Animal Physiology Pharmacol. Rev., September 1, 2002; 54(3): 431 - 467. [Abstract] [Full Text] [PDF]

				A. J. Carozzi, S. Roy, I. C. Morrow, A. Pol, B. Wyse, J. Clyde-Smith, I. A. Prior, S. J. Nixon, J. F. Hancock, and R. G. Parton Inhibition of Lipid Raft-dependent Signaling by a Dystrophy-associated Mutant of Caveolin-3 J. Biol. Chem., May 10, 2002; 277(20): 17944 - 17949. [Abstract] [Full Text] [PDF]

				M. A. Alonso and J. Millan The role of lipid rafts in signalling and membrane trafficking in T lymphocytes J. Cell Sci., March 13, 2002; 114(22): 3957 - 3965. [Abstract] [Full Text] [PDF]

				L. Vargas, B. F. Nore, A. Berglof, J. E. Heinonen, P. T. Mattsson, C. I. E. Smith, and A. J. Mohamed Functional Interaction of Caveolin-1 with Bruton's Tyrosine Kinase and Bmx J. Biol. Chem., March 8, 2002; 277(11): 9351 - 9357. [Abstract] [Full Text] [PDF]

				P. D. Cote, H. Moukhles, and S. Carbonetto Dystroglycan Is Not Required for Localization of Dystrophin, Syntrophin, and Neuronal Nitric-oxide Synthase at the Sarcolemma but Regulates Integrin alpha 7B Expression and Caveolin-3 Distribution J. Biol. Chem., February 8, 2002; 277(7): 4672 - 4679. [Abstract] [Full Text] [PDF]

				C. Minetti, M. Bado, P. Broda, F. Sotgia, C. Bruno, F. Galbiati, D. Volonte, G. Lucania, A. Pavan, E. Bonilla, et al. Impairment of Caveolae Formation and T-System Disorganization in Human Muscular Dystrophy with Caveolin-3 Deficiency Am. J. Pathol., January 1, 2002; 160(1): 265 - 270. [Abstract] [Full Text] [PDF]

				P. Thomsen, K. Roepstorff, M. Stahlhut, and B. van Deurs Caveolae Are Highly Immobile Plasma Membrane Microdomains, Which Are not Involved in Constitutive Endocytic Trafficking Mol. Biol. Cell, January 1, 2002; 13(1): 238 - 250. [Abstract] [Full Text] [PDF]

				B. Razani and M. P. Lisanti Two distinct caveolin-1 domains mediate the functional interaction of caveolin-1 with protein kinase A Am J Physiol Cell Physiol, October 1, 2001; 281(4): C1241 - C1250. [Abstract] [Full Text] [PDF]

				F. Galbiati, D. Volonte', J. Liu, F. Capozza, P. G. Frank, L. Zhu, R. G. Pestell, and M. P. Lisanti Caveolin-1 Expression Negatively Regulates Cell Cycle Progression by Inducing G0/G1 Arrest via a p53/p21WAF1/Cip1-dependent Mechanism Mol. Biol. Cell, August 1, 2001; 12(8): 2229 - 2244. [Abstract] [Full Text] [PDF]

				K. Hayashi, S. Matsuda, K. Machida, T. Yamamoto, Y. Fukuda, Y. Nimura, T. Hayakawa, and M. Hamaguchi Invasion Activating Caveolin-1 Mutation in Human Scirrhous Breast Cancers Cancer Res., March 1, 2001; 61(6): 2361 - 2364. [Abstract] [Full Text]

				R. Herrmann, V. Straub, M. Blank, C. Kutzick, N. Franke, E. N. Jacob, H.-G. Lenard, S. Kroger, and T. Voit Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy Hum. Mol. Genet., September 1, 2000; 9(15): 2335 - 2340. [Abstract] [Full Text] [PDF]

				F. Galbiati, D. Volonte', A. M. C. Brown, D. E. Weinstein, A. Ben-Ze'ev, R. G. Pestell, and M. P. Lisanti Caveolin-1 Expression Inhibits Wnt/beta -Catenin/Lef-1 Signaling by Recruiting beta -Catenin to Caveolae Membrane Domains J. Biol. Chem., July 21, 2000; 275(30): 23368 - 23377. [Abstract] [Full Text] [PDF]

				A. Schlegel and M. P. Lisanti A Molecular Dissection of Caveolin-1 Membrane Attachment and Oligomerization. TWO SEPARATE REGIONS OF THE CAVEOLIN-1 C-TERMINAL DOMAIN MEDIATE MEMBRANE BINDING AND OLIGOMER/OLIGOMER INTERACTIONS IN VIVO J. Biol. Chem., July 7, 2000; 275(28): 21605 - 21617. [Abstract] [Full Text] [PDF]

				F. Sotgia, J. K. Lee, K. Das, M. Bedford, T. C. Petrucci, P. Macioce, M. Sargiacomo, F. D. Bricarelli, C. Minetti, M. Sudol, et al. Caveolin-3 Directly Interacts with the C-terminal Tail of beta -Dystroglycan. IDENTIFICATION OF A CENTRAL WW-LIKE DOMAIN WITHIN CAVEOLIN FAMILY MEMBERS J. Biol. Chem., November 22, 2000; 275(48): 38048 - 38058. [Abstract] [Full Text] [PDF]

				F. Galbiati, D. Volonte, C. Minetti, D. B. Bregman, and M. P. Lisanti Limb-girdle Muscular Dystrophy (LGMD-1C) Mutants of Caveolin-3 Undergo Ubiquitination and Proteasomal Degradation. TREATMENT WITH PROTEASOMAL INHIBITORS BLOCKS THE DOMINANT NEGATIVE EFFECT OF LGMD-1C MUTANTS AND RESCUES WILD-TYPE CAVEOLIN-3 J. Biol. Chem., November 22, 2000; 275(48): 37702 - 37711. [Abstract] [Full Text] [PDF]